Clinical Trials Market Analysis by Phase (Phase I/II/III/IV), by Study Design (Interventional, Observational, Expanded Access), by Indication (Autoimmune, Pain management, Oncology, CNS condition, Diabetes, Obesity) and Segment Forecasts, 2014 - 2025

  • ID: 4396385
  • Report
  • 110 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Charles River Laboratory
  • ICON Plc
  • INC Research
  • PRA Health Sciences
  • QuintilesIMS
  • Service Benchmarking
  • MORE
The global clinical trials market is expected to reach USD 65.2 billion by 2025. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials.

Globalization of clinical trial has led to increase in investment in new product development in emerging countries thereby, having a positive impact on overall market. The availability of the vast array of services from drug discovery to post-marketing surveillance has further simplified the life for mid-size and small-scale pharmaceutical and biotechnological organizations by providing them the option to outsource what they think is beyond their core expertise. For instance, Pfizer currently has three CROs working with it to enhance its product portfolio and drive innovation. According to the partnership agreement with ICON in 2011, Pfizer would only preserve the scientific ownership for the trials and studies conducted by ICON, hence allowing the company to focus and further develop its capabilities in clinical trial designing.

Growing prevalence of disease and incidence of new disease is expected to give further boost to the clinical trial market. Worldwide population has varied disease profile with emerging countries having the most diverse disease profile. This is expected to boost the clinical trial of new or rare disease which otherwise would not have found any sponsors. More number of patients having a specific disease would act as a stimulus for biopharmaceutical companies to invest more in clinical trials for a disease segment.

Further key findings from the report suggest:
  • The global clinical trials market witnessed a lucrative growth in 2016 and is expected to grow at a CAGR of over 5.5% from 2017 to 2025
  • The market is expected to be dominated by Phase III as of 2016, with Phase I anticipated to witness the fastest growth
  • Increasing innovation and evolution of treatment is predicted to contribute towards growth of the expanded access trials segment
  • Based on indication, the oncology segment is anticipated to witness the fastest growth. According to various sources, more than USD 38.0 billion is currently being spent by the healthcare industry towards preclinical and clinical development of oncology therapy products
  • North America dominated the overall market in terms of revenue share in 2015 owing to the presence of big outsourcing firms and increasing R&D in the region.
  • Key players including Quintiles IMS, Paraxel International Corporation, Charles River Laboratories, ICON plc, SGS SA among the others dominate the global clinical trials market while representing maximum volume in 2016
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Charles River Laboratory
  • ICON Plc
  • INC Research
  • PRA Health Sciences
  • QuintilesIMS
  • Service Benchmarking
  • MORE
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Clinical Trials Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Globalization of clinical trials
3.1.1.2 Adoption of new technology in clinical research
3.1.1.3 Shift towards personalized medicine
3.1.1.4 Growing disease variation and prevalence
3.1.1.5 Increasing collaboration in biomedical research
3.1.1.6 Growth in CRO market
3.2 Market Restraint Analysis
3.2.1.1 Regulations in new drug development
3.2.1.2 Rising cost of clinical trials
3.2.1.3 Pricing pressure
3.3 Penetration & growth prospect mapping
3.4 Clinical trials– SWOT Analysis, By Factor (political & legal, economic and social)
3.5 Industry Analysis – Porter’s

Chapter 4 Clinical Trials Market: Phase Estimates & Trend Analysis
4.1 Clinical trials market: Phase movement analysis
4.2 Clinical trials market: Phase movement analysis
4.3 Phase I
4.4 Phase II
4.5 Phase III
4.6 Phase IV

Chapter 5 Clinical Trials Market: Study Design Estimates & Trend Analysis
5.1 Clinical trials market: Study Design movement analysis
5.2 Clinical trials market: Study design movement analysis
5.3 Interventional
5.4 Observational
5.5 Expanded access trials

Chapter 6 Clinical Trials Market: Indication Estimates & Trend Analysis
6.1 Clinical trials market: Indication movement analysis
6.2 Clinical trials market: Indication movement analysis
6.3 Autoimmune/inflammation
6.3.1 Global autoimmune based clinical trials market, 2014 - 2025 (USD Million)
6.3.2 Rheumatoid arthritis
6.3.2.1 Global rheumatoid arthritis based clinical trials market, 2014 - 2025 (USD Million)
6.3.3 Multiple sclerosis
6.3.3.1 Global multiple sclerosis based clinical trials market, 2014 - 2025 (USD Million)
6.3.4 Osteoarthritis
6.3.4.1 Global osteoarthritis based clinical trials market, 2014 - 2025 (USD Million)
6.3.5 IrriTable Bowel Disease (IBD)
6.3.5.1 Global IBD based clinical trials market, 2014 - 2025 (USD Million)
6.3.6 Others
6.3.6.1 Global other disease based autoimmune clinical trials market, 2014 - 2025 (USD Million)
6.4 Pain management
6.4.1 Global pain management based clinical trials market, 2014 - 2025 (USD Million)
6.4.2 Chronic pain
6.4.2.1 Global chronic pain based clinical trials market, 2014 - 2025 (USD Million)
6.4.3 Acute pain
6.4.3.1 Global acute pain based clinical trials market, 2014 - 2025 (USD Million)
6.5 Oncology
6.5.1 Global oncology based clinical trials market, 2014 - 2025 (USD Million)
6.5.2 Blood cancer
6.5.2.1 Global blood cancer based clinical trials market, 2014 - 2025 (USD Million)
6.5.3 Solid tumors
6.5.3.1 Global solid tumors based clinical trials market, 2014 - 2025 (USD Million)
6.5.4 Others
6.5.4.1 Global other cancer based clinical trials market, 2014 - 2025 (USD Million)
6.6 CNS conditions
6.6.1 Global CNS conditions based clinical trials market, 2014 - 2025 (USD Million)
6.6.2 Epilepsy
6.6.2.1 Global epilepsy based clinical trials market, 2014 - 2025 (USD Million)
6.6.3 Parkinson’s Disease (PD)
6.6.3.1 Global PD based clinical trials market, 2014 - 2025 (USD Million)
6.6.4 Huntington’s Disease (HD)
6.6.4.1 Global HD based clinical trials market, 2014 - 2025 (USD Million)
6.6.5 Stroke
6.6.5.1 Global stroke based clinical trials market, 2014 - 2025 (USD Million)
6.6.6 Traumatic Brain Injury (TBI)
6.6.6.1 Global TBI based clinical trials market, 2014 - 2025 (USD Million)
6.6.7 Amyotrophic Lateral Sclerosis (ALS)
6.6.7.1 Global ALS based clinical trials market, 2014 - 2025 (USD Million)
6.6.8 Muscle regeneration
6.6.8.1 Global muscle regeneration based clinical trials market, 2014 - 2025 (USD Million)
6.6.9 Others
6.6.9.1 Global other disease based CNS clinical trials market, 2014 - 2025 (USD Million)
6.7 Diabetes
6.7.1 Global diabetes based clinical trials market, 2014 - 2025 (USD Million)
6.8 Obesity
6.8.1 Global Obesity based clinical trials market, 2014 - 2025 (USD Million)
6.9 Cardiovascular
6.9.1 Global cardiovascular based clinical trials market, 2014 - 2025 (USD Million)
6.10 Other indications
6.10.1 Global other indication based clinical trials market, 2014 - 2025 (USD Million)

Chapter 7 Clinical Trials Market: Regional Estimates & Trend Analysis, by Phase, Study Design, & Indication
7.1 Clinical trials market share by region, 2016 & 2025
7.2 North America
7.2.1 North America clinical trials market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. clinical trials market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada clinical trials market, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe clinical trials market, 2014 - 2025 (USD Million)
7.3.2 UK
7.3.2.1 UK clinical trials market, 2014 - 2025 (USD Million)
7.3.3 Germany
7.3.3.1 Germany clinical trials market, 2014 - 2025 (USD Million)
7.3.4 France
7.3.4.1 France clinical trials market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific clinical trials market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan clinical trials market, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China clinical trials market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America clinical trials market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil clinical trials market, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico clinical trials market, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 MEA clinical trials market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa clinical trials market, 2014 - 2025 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia clinical trials market, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 QuintilesIMS
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 Parexel International Corporation
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 Pharmaceutical Product Development, LLC
8.1.3.1 Company Overview
8.1.3.2 Product Benchmarking
8.1.3.3 Strategic Initiatives
8.1.4 Charles River Laboratory
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 ICON Plc
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Wuxi AppTec Inc.
8.1.6.1 Company Overview
8.1.6.2 Product Benchmarking
8.1.6.3 Strategic Initiatives
8.1.7 PRA Health Sciences
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Service Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 Chiltern International Ltd.
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Product Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 INC Research
8.1.9.1 Company Overview
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 SGS SA
8.1.10.1 Company Overview
8.1.10.2 Financial Performance
8.1.10.3 Service Benchmarking
8.1.10.4 Strategic Initiatives

List of Tables
Table 1 North America clinical trial market estimates and forecast by phase, 2014 - 2025
Table 2 North America clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
Table 3 North America clinical trial market estimates and forecast by indication, 2014 - 2025
Table 4 North America. clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 5 North America clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 6 North America clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 7 North America clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
Table 8 North America clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 9 North America clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 10 North America clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 11 U.S. clinical trial market estimates and forecast by phase, 2014 - 2025
Table 12 U.S. clinical trial market estimates and forecast by study design (USD Million)
Table 13 U.S. clinical trial market estimates and forecast by indication, 2014 - 2025
Table 14 U.S. clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 15 U.S. clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 16 U.S. clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 17 U.S. clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
Table 18 U.S. clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 19 U.S. clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 20 U.S. clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 21 U.S. clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 22 Canada clinical trial market estimates and forecast by phase, 2014 - 2025
Table 23 Canada clinical trial market estimates and forecast by study design (USD Million)
Table 24 Canada clinical trial market estimates and forecast by indication, 2014 - 2025
Table 25 Canada clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 26 Canada clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 27 Canada clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 28 Canada clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
Table 29 Canada clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 30 Canada clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 31 Canada clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 32 Canada clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 33 Europe clinical trialmarket estimates and forecast by phase, 2014-2025
Table 34 Europe clinical trial market estimates and forecast by study design, 2014 - 2025
Table 35 Europe clinical trial market estimates and forecast by indication (USD Million)
Table 36 Europe clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 37 Europe clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 38 Europe clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 39 Europe clinical trial CNS conditions market estimates and forecast by indication, 2014 - 2025
Table 40 Europe clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 41 Europe clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 42 Europe clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 43 Europe clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 44 U.K clinical trial market estimates and forecast by phase, 2014 - 2025
Table 45 U.K clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
Table 46 U.K clinical trial market estimates and forecast by indication, 2014 - 2025
Table 47 U.K clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 48 U.K clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 49 U.K clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 50 U.K clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 51 U.K clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 52 U.K clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 53 U.K clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 54 U.K clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 55 Germany clinical trial market estimates and forecast by phase, 2014 - 2025 (USD Million)
Table 56 Germany clinical trial market estimates and forecast by study design, 2014 - 2025
Table 57 Germany clinical trial market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 58 Germany clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 59 Germany clinical trial pain management market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 60 Germany clinical trial oncology market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 61 Germany clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 62 Germany clinical trial diabetes market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 63 Germany clinical trial obesity market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 64 Germany clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 65 Germany clinical trial other market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 66 Asia Pacific clinical trial market estimates and forecast by phase, 2014 - 2025
Table 67 Asia Pacific clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
Table 68 Asia Pacific clinical trial market estimates and forecast by indication, 2014 - 2025
Table 69 Asia Pacific clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 70 Asia Pacific clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 71 Asia Pacific clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 72 Asia Pacific clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 73 Asia Pacific clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 74 Asia Pacific clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 75 Asia Pacific clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 76 Asia Pacific clinical trial other market estimates and forecast by indication, 2014-2025.
Table 77 China clinical trial market estimates and forecast by phase, 2014 - 2025
Table 78 China clinical trial market estimates and forecast by study design (USD Million)
Table 79 China clinical trial market estimates and forecast by indication, 2014 - 2025
Table 80 China clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 81 China clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 82 China clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 83 China clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 84 China clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 85 China clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 86 China clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 87 China clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 88 Japan clinical trial market estimates and forecast by phase, 2014 - 2025
Table 89 Japan clinical trial market estimates and forecast by study design (USD Million)
Table 90 Japan clinical trial market estimates and forecast by indication, 2014 - 2025
Table 91 Japan clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 92 Japan clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 93 Japan clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 94 Japan clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 95 Japan clinical trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 96 Japan clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 97 Japan clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 98 Latin America other clinical trial market estimates and forecast by phases, 2014 - 2025(USD Million)
Table 99 Latin America clinical trial market estimates and forecast by study design, 2014 - 2025
Table 100 Latin America clinical trial market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 101 Latin America clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 102 Latin America clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 103 Latin America clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 104 Latin America clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 105 Latin America trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 106 Latin America clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 107 Latin America clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 108 Latin America clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 109 Brazil clinical trial market estimates and forecast by phase, 2014 - 2025
Table 110 Brazil clinical trial market estimates and forecast by study design (USD Million)
Table 111 Brazil clinical trial market estimates and forecast by indication, 2014 - 2025
Table 112 Brazil clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 113 Brazil clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 114 Brazil clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 115 Brazil clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 116 Brazil trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 117 Brazil clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 118 Brazil clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 119 Brazil clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 120 Mexico clinical trial market estimates and forecast by phase, 2014 - 2025 (USD Million)
Table 121 Mexico clinical trial market estimates and forecast by study design, 2014 - 2025
Table 122 Mexico clinical trial market estimates and forecast by indication, 2014 - 2025 (USD Million)
Table 123 Mexico clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 124 Mexico clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 125 Mexico clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 126 Mexico clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 127 Mexico trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 128 Mexico clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 129 Mexico clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 130 Middle East Asia clinical trial market estimates and forecast by phase, 2014 - 2025
Table 131 Middle East Asia clinical trial market estimates and forecast by study design, 2014 - 2025 (USD Million)
Table 132 Middle East Asia clinical trial market estimates and forecast by indication, 2014 - 2025
Table 133 Middle East Asia clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 134 Middle East Asia clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 135 Middle East Asia clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 136 Middle East Asia clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 137 Middle East Asia trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 138 Middle East Asia clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 139 Middle East Asia clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 140 Middle East Asia clinical trial other market estimates and forecast by indication, 2014 - 2025
Table 141 South Africa clinical trial market estimates and forecast by phase, 2014 - 2025
Table 142 South Africa clinical trial market estimates and forecast by study design (USD Million)
Table 143 South Africa clinical trial market estimates and forecast by indication, 2014 - 2025
Table 144 South Africa clinical trial autoimmune/inflammation market estimates and forecast by indication, 2014 - 2025
Table 145 South Africa clinical trial pain management market estimates and forecast by indication, 2014 - 2025
Table 146 South Africa clinical trial oncology market estimates and forecast by indication, 2014 - 2025
Table 147 South Africa clinical trial CNS condition market estimates and forecast by indication, 2014 - 2025
Table 148 South Africa trial diabetes market estimates and forecast by indication, 2014 - 2025
Table 149 South Africa clinical trial obesity market estimates and forecast by indication, 2014 - 2025
Table 150 South Africa clinical trial cardiovascular market estimates and forecast by indication, 2014 - 2025
Table 151 South Africa clinical trial other market estimates and forecast by indication, 2014 - 2025

List of Figures
FIG. 1 Market summary, 2016 (USD Million)
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Pharmaceutical R&D spending, 2007 - 2012 (USD Billion)
FIG. 6 Market restraint relevance analysis (Current & future impact)
FIG. 7 Penetration & growth prospect mapping
FIG. 8 SWOT Analysis, By Factor (political & legal, economic and social)
FIG. 9 Porter’s Five Forces Analysis
FIG. 10 Clinical trials market phase outlook key takeaways
FIG. 11 Clinical trials market: Phase movement analysis
FIG. 12 Global phase I market, 2014 - 2025 (USD Million)
FIG. 13 Global phase II market, 2014 - 2025 (USD Million)
FIG. 14 Global phase III market, 2014 - 2025 (USD Million)
FIG. 15 Global phase IV market, 2014 - 2025 (USD Million)
FIG. 16 Clinical trials market study design outlook key takeaways
FIG. 17 Clinical trials market: Study design movement analysis
FIG. 18 Global interventional market, 2014 - 2025 (USD Million)
FIG. 19 Global observational market, 2014 - 2025 (USD Million)
FIG. 20 Global expanded access trials market, 2014 - 2025 (USD Million)
FIG. 21 Clinical trials market indication outlook key takeaways
FIG. 22 Clinical trials market: Indication movement analysis
FIG. 23 Global autoimmune based clinical trials market, 2014 - 2025 (USD Million)
FIG. 24 Global rheumatoid arthritis based clinical trials market, 2014 - 2025 (USD Million)
FIG. 25 Global multiple sclerosis based clinical trials market, 2014 - 2025 (USD Million)
FIG. 26 Global osteoarthritis based clinical trials market, 2014 - 2025 (USD Million)
FIG. 27 Global IBD based clinical trials market, 2014 - 2025 (USD Million)
FIG. 28 Global other disease based autoimmune clinical trials market, 2014 - 2025 (USD Million)
FIG. 29 Global pain management based clinical trials market, 2014 - 2025 (USD Million)
FIG. 30 Global chronic pain based clinical trials market, 2014 - 2025 (USD Million)
FIG. 31 Global acute pain based clinical trials market, 2014 - 2025 (USD Million)
FIG. 32 Global oncology based clinical trials market, 2014 - 2025 (USD Million)
FIG. 33 Global blood cancer based clinical trials market, 2014 - 2025 (USD Million)
FIG. 34 Global solid tumors based clinical trials market, 2014 - 2025 (USD Million)
FIG. 35 Global other cancer based clinical trials market, 2014 - 2025 (USD Million)
FIG. 36 Global CNS conditions based clinical trials market, 2014 - 2025 (USD Million)
FIG. 37 Global epilepsy based clinical trials market, 2014 - 2025 (USD Million)
FIG. 38 Global PD based clinical trials market, 2014 - 2025 (USD Million)
FIG. 39 Global HD based clinical trials market, 2014 - 2025 (USD Million)
FIG. 40 Global stroke based clinical trials market, 2014 - 2025 (USD Million)
FIG. 41 Global TBI based clinical trials market, 2014 - 2025 (USD Million)
FIG. 42 Global ALS based clinical trials market, 2014 - 2025 (USD Million)
FIG. 43 Global muscle regeneration based clinical trials market, 2014 - 2025 (USD Million)
FIG. 44 Global other disease based CNS clinical trials market, 2014 - 2025 (USD Million)
FIG. 45 Global diabetes based clinical trials market, 2014 - 2025 (USD Million)
FIG. 46 Global Obesity based clinical trials market, 2014 - 2025 (USD Million)
FIG. 47 Global cardiovascular based clinical trials market, 2014 - 2025 (USD Million)
FIG. 48 Global other indication based clinical trials market, 2014 - 2025 (USD Million)
FIG. 49 Regional market place: Key takeaways
FIG. 50 Regional outlook, 2016 & 2025
FIG. 51 North America clinical trials market, 2014 - 2025 (USD Million)
FIG. 52 U.S. clinical trials market, 2014 - 2025 (USD Million)
FIG. 53 Canada clinical trials market, 2014 - 2025 (USD Million)
FIG. 54 Europe clinical trials market, 2014 - 2025 (USD Million)
FIG. 55 UK clinical trials market, 2014 - 2025 (USD Million)
FIG. 56 Germany clinical trials market, 2014 - 2025 (USD Million)
FIG. 57 France clinical trials market, 2014 - 2025 (USD Million)
FIG. 58 Asia Pacific clinical trials market, 2014 - 2025 (USD Million)
FIG. 59 Japan clinical trials market, 2014 - 2025 (USD Million)
FIG. 60 China clinical trials market, 2014 - 2025 (USD Million)
FIG. 61 Latin America clinical trials market, 2014 - 2025 (USD Million)
FIG. 62 Brazil clinical trials market, 2014 - 2025 (USD Million)
FIG. 63 Mexico clinical trials market, 2014 - 2025 (USD Million)
FIG. 64 MEA clinical trials market, 2014 - 2025 (USD Million)
FIG. 65 South Africa clinical trials market, 2014 - 2025 (USD Million)
FIG. 66 Saudi Arabia clinical trials market, 2014 - 2025 (USD Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Charles River Laboratory
  • Chiltern International Ltd.
  • ICON Plc
  • INC Research
  • PRA Health Sciences
  • Parexel International Corporation
  • Pharmaceutical Product Development, LLC
  • QuintilesIMS
  • SGS SA
  • Service Benchmarking
  • Wuxi AppTec Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll